5TH STRAIGHT QUARTER OF PHARMACIA GROWTH

From: The Record (Bergen County, NJ) | Date: July 29, 1999| Author: | Copyright information

DAVID SHOOK, Staff Writer
The Record (Bergen County, NJ)
07-29-1999
5TH STRAIGHT QUARTER OF PHARMACIA GROWTH -- 15% EARNINGS RISE MEETS EXPECTATIONS

By DAVID SHOOK, Staff Writer
Date: 07-29-1999, Thursday
Section: BUSINESS
Edition: All Editions -- 2 Star B, 2 Star P, 1 Star Early

Pharmacia & Upjohn Inc., still getting comfortable in its new
headquarters in Peapack-Gladstone, met stock analysts' expectations
Wednesday by posting a 15 percent rise in second-quarter earnings.

The drug maker, which markets the top-selling glaucoma treatment
Xalatan and the cancer drug Camptosar, has now ...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

Pharmacia & Upjohn to acquire Sugen and its promising portfolio of cancer drugs
; The Deal: Pharmacia & Upjohn has agreed to acquire Sugen Inc...requires that at the time of the deal's completion, Pharmacia shares must be trading in the range of $49.22...end of the third quarter of 1999. On the news, Pharmacia & Upjohn was up $1.375, or 2.6%, at $54.6875...California ...
U.S. to speed up release of cancer drugs to public Move is expected to cut years from often-lengthy approval process
; ...up release of promising experimental cancer drugs to the public, a move expected to shave...unnecessarily costly. Clinton, noting that cancer drugs often took years to reach the market...Kelley, died of breast cancer. Some 300 cancer drugs are currently in various stages of testing...
Expert calls for Italian-style approach to cancer drugs.(Features)
; ...access to breakthrough and expensive cancer drugs. The Italian government has signed an...conference in Cardiff that to fund all new cancer drugs would cost Velindre NHS Trust upwards...patients' treatments. Currently, new cancer drugs are only available to all patients on...
Britain accused of delaying new cancer drugs.
; ...the European league for giving out new cancer drugs, a damning report reveals. Patients...being below average adopters of new cancer drugs.' The report, to be presented to the...at availability of a whole range of cancer drugs, including Herceptin which boosts women...
VENTURE TO SELL LOWER-COST CANCER DRUGS
; ...09-10-1993 VENTURE TO SELL LOWER-COST CANCER DRUGS Date: 09-10-1993, Friday Section: BUSINESS...community-based cancer specialists with lower-cost cancer drugs and services. The alliance will market cancer drugs and related services to the fast-growing...
U.S. backs off on plan for cancer drugs
; U.S. backs off on plan for cancer drugs New York Times Saturday, September 9...a plan to cut Medicare payments for cancer drugs given to hundreds of thousands of patients...believed that Medicare paid too much for cancer drugs. But, she said, the government will...
Call for cancer drugs charity.(News)
; ...to be set up to help people refused cancer drugs on the NHS. The Gateshead East and Washington...has called for greater access to new cancer drugs and has asked the Government to fund...inspired to campaign for fairer access to cancer drugs after two of her constituents were ...
?Controversial cancer drugs policy is wrong?
; ...NHS services to patients who pay for cancer drugs privately needs reviewing, according...should be changed so patients who pay for cancer drugs privately are not penalised by having...NorthEast primary care trusts on which cancer drugs it should fund before a ruling by Nice...
Cancer drugs need coverage
; ...that it will slash reimbursement for cancer drugs has caused dismay among physicians who...office -- many people do not realize that cancer drugs available exclusively in oral form...FDA data reveals that 30 percent of cancer drugs approved since 1995 are available only...
FDA streamlines approval process for new cancer drugs
; ...simplifying its process for approving new cancer drugs to get them to patients more quickly...Products now have authority to approve new cancer drugs without getting approval from higher-u...other regulatory actions related to cancer drugs without getting approval from above...